Integrative Medicine: The Inevitable Direction of Future Medical Development

Acknowledgments

None.

Funding

This editorial received no specific grant from any public, commer-cial, or not-for-profit funding agency.

Conflict of interest

The author has no conflict of interest to declare.

References

[1] Fan D. Holistic integrative medicine: toward a new era of medical ad-vancement. Front Med 2017; 11:152-159. doi:10.1007/s11684-017-0499-6,PMID:28044221.

[2] Zhang Z, Zhu M. Holistic view of TCM on cancer integrative thera-py. Future Integr Med 2023; 2(3):159-167. doi:10.14218/FIM.2023.00048.

[3] Wang JB, Xiao XH. On indirect actions of Chinese medicines and in-novation of indirect-acting Chinese medicines. Zhongguo Zhong Yao Za Zhi 2021; 46(21):5443-5449. doi:10.19540/j.cnki.cjcmm.20210978.601,PMID:34951194.

[4] Gao Y, Wang JB. Commentary: Indirect action pattern: A remote and cross-organ pharmacological mechanism for drug innova-tion. Acta Pharm Sin B 2022; 12(8):3448-3450. doi:10.1016/j.apsb.2022.05.025,PMID:35967286.

[5] Wang J, Xiao X, Khan I, Liu Q. Announcing a new journal: Future in-tegrative medicine. Future Integr Med 2022; 1(1):1. doi:10.14218/FIM.2022.00000.

[6] Yang X, Wang T. Visual analysis of research hotspots in amyo-trophic lateral sclerosis based on bibliometrics. Future Integr Med 2023; 2(3):168-178. doi:10.14218/FIM.2023.00019.

[7] Zhao Y, Cheng C, Gao Y, Wang J. Integrative review on the chemical components, pharmacology and toxicology of psoralea Corylifolia L. (Bu Gu Zhi). Future Integr Med 2023; 2(1):36-47. doi:10.14218/FIM.2022.00051.